Abstract:Abstract Background RNA editing is a process that increases transcriptome diversity, often through Adenosine Deaminases Acting on RNA (ADARs) that catalyze the deamination of adenosine to inosine. ADAR editing plays an important role in regulating brain function and immune activation, and is dynamically regulated during brain development. Additionally, the ADAR1 p150 isoform is induced by interferons in viral infection and plays a role in antiviral immune response. However, the question of how virus-induced ADAR expression affects host transcriptome editing remains largely unanswered. This question is particularly relevant in the context of congenital infections, given the dynamic regulation of ADAR editing during brain development, the importance of this editing for brain function, and subsequent neurological symptoms of such infections, including microcephaly, sensory issues, and other neurodevelopmental abnormalities. Here, we begin to address this question, examining ADAR expression in publicly available datasets of congenital infections of human cytomegalovirus (HCMV) microarray expression data, as well as mouse cytomegalovirus (MCMV) and mouse/ human induced pluripotent neuroprogenitor stem cell (hiNPC) Zika virus (ZIKV) RNA-seq data. Results We found that in all three datasets, ADAR1 was overexpressed in infected samples compared to uninfected samples. In the RNA-seq datasets, editing rates were also analyzed. In all mouse infections cases, the number of editing sites was significantly increased in infected samples, albeit this was not the case for hiNPC ZIKV samples. Mouse ZIKV samples showed altered editing of well-established protein-recoding sites such as Gria3, Grik5, and Nova1, as well as editing sites that may impact miRNA binding. Conclusions Our findings provide evidence for changes in ADAR expression and subsequent dysregulation of ADAR editing of host transcriptomes in congenital infections. These changes in editing patterns of key neural genes have potential significance in the development of neurological symptoms, thus contributing to neurodevelopmental abnormalities. Further experiments should be performed to explore the full range of editing changes that occur in different congenital infections, and to confirm the specific functional consequences of these editing changes.

RNA editing in response to COVID-19 vaccines: unveiling dynamic epigenetic regulation of host immunity

RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection

Virus-specific Editing Identification Approach Reveals the Landscape of A-to-I Editing and Its Impacts on SARS-CoV-2 Characteristics and Evolution

Ocular A-to-I RNA editing signatures associated with SARS-CoV-2 infection

A comprehensive study on cellular RNA editing activity in response to infections with different subtypes of influenza a viruses

ADAR mediated A-to-I RNA editing affects SARS-CoV-2 characteristics and fuels its evolution

Detection of A-to-I RNA Editing in SARS-COV-2

A-to-I RNA editing — immune protector and transcriptome diversifier

The roles of RNA editing in cancer immunity through interacting with interferon

RNA editing underlies genetic risk of common inflammatory diseases

Reovirus infection induces transcriptome-wide unique A-to-I editing changes in the murine fibroblasts

Host-mediated RNA editing in viruses

Global Analysis of A-to-I RNA Editing Reveals Association with Common Disease Variants

RNA editing in the forefront of epitranscriptomics and human health

Multimodal CRISPR screens uncover DDX39B as a global repressor of A-to-I RNA editing

The implications of APOBEC3-mediated C-to-U RNA editing for human disease

RNA editing in cancer impacts mRNA abundance in immune response pathways

Adenosine-to-inosine RNA editing in the immune system: friend or foe?

Changes in ADAR RNA editing patterns in CMV and ZIKV congenital infections

Genomic Landscape and Regulation of RNA Editing in Pekin Ducks Susceptible to Duck Hepatitis A Virus Genotype 3 Infection

Genome-Wide Profiling Reveals Alternative Polyadenylation of Innate Immune-Related mRNA in Patients With COVID-19